Search research articles
Contact Us
Filters
Showing results (21-30 of 45) with videos related to
Page
of 5
Sort By:
Biochemical Pharmacology
|
February 1, 1976
Tumour inhibitory triazenes: structural requirements for an active metabolite
T A Connors, P M Goddard, K Merai, et al.
Biochemical Pharmacology
|
August 1, 1973
Studies on the mechanism of action of the tumour inhibitory triazenes
R C Audette, T A Connors, H G Mandel, et al.
Cancer Drug Delivery
|
January 1, 1984
Delivery of ricin and abrin A-chains to human carcinoma cells in culture following covalent linkage to monoclonal antibody LICR-LOND-Fib 75
J A Forrester, D P McIntosh, A J Cumber, et al.
European Journal of Cancer
|
January 1, 1973
The selective concentration of sulphadiazine and related compounds in malignant tissue
G Abel, T A Connors, W C Ross, et al.
Biochemical Pharmacology
|
February 1, 1986
Fate of an antibody-ricin A chain conjugate administered to normal rats
N R Worrell, A J Cumber, G D Parnell, et al.
Journal of Immunological Methods
|
January 21, 1985
Variants of lymphoid lines produced with ricin A-chain monoclonal antibody conjugates
J A Lowe, N R Ling, J A Forrester, et al.
Cancer Treatment Reports
|
August 1, 1977
Regression of human lung tumor xenografts induced by water-soluble analogs of hexamethylmelamine
T A Connors, A J Cumber, W C Ross, et al.
Methods in Enzymology
|
January 1, 1985
Preparation of antibody-toxin conjugates
A J Cumber, J A Forrester, B M Foxwell, et al.
Haematology and Blood Transfusion
|
January 1, 1983
Monoclonal antibody therapy: "model" experiments with toxin-conjugated antibodies in mice and rats
P E Thorpe, S I Detre, D W Mason, et al.
Experientia
|
March 15, 1981
The effect of abrin, anti-lymphocyte globulin and their conjugates on the immune response of mice to sheep red blood cells
D C Edwards, A Smith, W C Ross, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 45) with videos related to
Sort By:
Page
of 5
Biochemical Pharmacology
|
February 1, 1976
Tumour inhibitory triazenes: structural requirements for an active metabolite
T A Connors, P M Goddard, K Merai, et al.
Biochemical Pharmacology
|
August 1, 1973
Studies on the mechanism of action of the tumour inhibitory triazenes
R C Audette, T A Connors, H G Mandel, et al.
Cancer Drug Delivery
|
January 1, 1984
Delivery of ricin and abrin A-chains to human carcinoma cells in culture following covalent linkage to monoclonal antibody LICR-LOND-Fib 75
J A Forrester, D P McIntosh, A J Cumber, et al.
European Journal of Cancer
|
January 1, 1973
The selective concentration of sulphadiazine and related compounds in malignant tissue
G Abel, T A Connors, W C Ross, et al.
Biochemical Pharmacology
|
February 1, 1986
Fate of an antibody-ricin A chain conjugate administered to normal rats
N R Worrell, A J Cumber, G D Parnell, et al.
Journal of Immunological Methods
|
January 21, 1985
Variants of lymphoid lines produced with ricin A-chain monoclonal antibody conjugates
J A Lowe, N R Ling, J A Forrester, et al.
Cancer Treatment Reports
|
August 1, 1977
Regression of human lung tumor xenografts induced by water-soluble analogs of hexamethylmelamine
T A Connors, A J Cumber, W C Ross, et al.
Methods in Enzymology
|
January 1, 1985
Preparation of antibody-toxin conjugates
A J Cumber, J A Forrester, B M Foxwell, et al.
Haematology and Blood Transfusion
|
January 1, 1983
Monoclonal antibody therapy: "model" experiments with toxin-conjugated antibodies in mice and rats
P E Thorpe, S I Detre, D W Mason, et al.
Experientia
|
March 15, 1981
The effect of abrin, anti-lymphocyte globulin and their conjugates on the immune response of mice to sheep red blood cells
D C Edwards, A Smith, W C Ross, et al.
Page
of 5